Session Details
[27-59-pm2]HPLC analysis 1
Fri. Mar 27, 2026 3:30 PM - 5:30 PM JST
Fri. Mar 27, 2026 6:30 AM - 8:30 AM UTC
Fri. Mar 27, 2026 6:30 AM - 8:30 AM UTC
Room 59 (4001, Bldg. 4, Area 4 [B1F]) (2)
Discusser: Naoya Kishikawa, Kazumasa Zaima
[27-59-pm2-11]Development of a new pH-responsive DES homogeneous liquid–liquid microextraction method for the determination of preservatives and antioxidants in liquid samples
○Fang-Yi Liao1, Chia-Hsien Feng1 (1. Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University)
[27-59-pm2-12]Development of HPLC-UV method using a C4 column for the simultaneous quantification of oseltamivir and oseltamivir acid and application to membrane permeability test in Caco-2 cells
○Miyu Katagiri1, Masaya Takemoto1, Yasuhiko Higashi1 (1. Fac. Pharm. Sci., Hokuriku Univ.)
[27-59-pm2-13]Development of a quantitative method for mirogabalin using HPLC-fluorescence detection and application to membrane permeability test in Caco-2 cells
○Erika Iguchi1, Masaya Takemoto1, Yasuhiko Higashi1 (1. Fac. Pharm. Sci., Hokuriku Univ.)
[27-59-pm2-14]Development of a quantitative method for pregabalin using HPLC-fluorescence detection and application to membrane permeability test in Caco-2 cells
○Noe Tsuchihashi1, Masaya Takemoto1, Yasuhiko Higashi1 (1. Fac. Pharm. Sci., Hokuriku Univ.)
[27-59-pm2-15]Examination of conditions for nucleic acid recovery from serum using solid-phase extraction.
○yuko yui1, kousei tanaka1, shigenori ota1, kazuyuki ishii1 (1. GL Sciences Inc.)
[27-59-pm2-16]Investigation of solid-phase extraction methods for pretreatment of PFAS analysis in serum matrices.
○Takuto Sakai1, Reika Takahara1, Takumi Kunieda1, Kazuyuki Ishii1, Manabu Takayanagi1, Shigenori Ota1 (1. GL Sciences Inc.)
[27-59-pm2-17]Development of LV analysis technique with the affinity chromatography column using Low-density lipoprotein receptor (LDLR)
○Kazuki Aida1, Kohei Yoshida1, Keita Omura1, Yusuke Nezu1, Tooru Tanaka1, Teruhiko Ide1 (1. Tosoh Corporation)
[27-59-pm2-18]Evaluation of chiral stability of some pharmaceuticals having a phenylethanolamine structure by enantioselective HPLC columns
○Hiroyuki Nishi1, Haruka Matsumoto1, Yuina Kawamura1, Yoko Nunome1, Kohei Kawabata1 (1. Fac. Pharm., Yasuda Women's Univ.)
[27-59-pm2-19]Platform SEC Methods for Gene Therapy Drug Substances
Case Studies on AAV and Examples of LNP and Nucleic Acids Analyses
○Hiroko Iwasaki1, Lavelay Kizekai2, Mateusz Imiolek3, Balasubrahmanyam Addepalli2, Valeria Barattini4, Szabolcs Fekete3, Matthew A. Lauber2 (1. Nihon Waters , 2. Waters Corp., USA, 3. Waters Corp., Switzerland, 4. Waters Corp., UK)
[27-59-pm2-20]pH-Dependent Characterization of Glycan GU Values and Development of a Correction Model toward Antibody Glycan Analysis
○Naoko Hashimoto1, Izumi Sakamoto1,3, Haruhiko Ogasawara2, Kazumi Sato2, Ryouhei Uematsu1, Hiroyuki Monma2, Shinichirou Yoshida2, Akio Kanatani1, Eunsang Kwon2 (1. GlyTech., Inc. , 2. Research and Analytical Center for Giant Molecules, Grad. Sch. Sci., Tohoku Univ., 3. Grad. Sch. Med., Tohoku Univ.)